Needle-free Injection System Market – Insights
Needle-free injection system is an efficient way to administer medications. It involves administering medications without penetrating the middle through the skin. Some of the advantages of the system include, effective administration of medications and better patient compliance especially in pediatric and geriatric patients and patients suffering from chronic diseases who require daily injection administration. Moreover, needle-free injection system also allows self-medication and eliminates needle phobia. It also allows drug delivery of viscous drugs, which is otherwise challenging using conventional needle syringe system. The system can also be used to administer biological drugs that are unstable due to risk of protein denaturation as it does not have silicon oil or tungsten material in its primary container and can maintain biological integrity. Another major advantage of needle-free injection system over conventional needle syringe system is its reusable and ability to delivers drug faster.
Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/1681
Needle-free Injection System Market: Drivers
High incidents of needle associated injuries and needle phobia in pediatric and geriatric patients is a major factor boosting growth of the global needle-free injection system market. For instance, according to a study published in Behavioral Neurology, 2014, around 3-4 % of the world population faces needle phobia. Needle phobia adversely impacts vaccination in children and hospital visits. Therefore, increasing demand for vaccines and other biologic products is also expected to propel growth of the needle-free injection system market. For instance, according to a study published in the Clinical Journal of Pain in 2015, there were 12 billion vaccination every year worldwide, most of which required injecting drug with a needle syringe system. According to the World Health Organization (WHO) 2018, globally, around 86% of infants are vaccinated against 26 diseases. However, 19.5 million children are unvaccinated leading to death of 2-3 million children every year.
Management and treatment of chronic diseases such as diabetes often requires daily dose of insulin. This daily dose is usually administered through needles. Therefore, lack of confidence in self-injection of insulin may lead to lack of adherence to treatment. Increasing R&D in biologics and biosimilars is also expected to boost growth of the market. The use of biologicals has increased for the treatment of GI tract diseases (ulcerative colitis and Crohn’s disease), central nervous system associated diseases (multiple sclerosis and Alzheimer’s disease), and cancer. High prevalence of communicable diseases caused due to conventional needle, increasing geriatric population, and growing awareness about safe injection practices are some of the other factors contributing to growth of the global needle-free injection system market.
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1681
Needle-free Injection System Market: Restraints
However, per unit cost of needle-free injection is expected to hinder growth of the market. Moreover, this emerging technology does not have wider penetration yet and its use is still very limited.
Needle-free Injection System Market: Regional Analysis
North America is expected to account for the largest market share over the forecast period, owing to increasing incidence of chronic disorders such as diabetes and cancer. For instance, according to the American Cancer Society, 2018, cancer is the second leading cause of death after cardiovascular disease in the U.S. Furthermore, around 1.7 million new cancer cases were reported by 2017 in this region. Increasing approval of biologics is also expected to boost growth of the market in North America. For instance, in 2017, the U.S. Food and Drug Administration (FDA) approved over 20 biologic formulations. Increasing prevalence of diabetes and need for vaccination is expected to boost growth of the market in Asia Pacific. For instance, according to the 2017 Diabetes Atlas report, there were over 240 million diabetes patients in Asia Pacific.
Needle-free Injection System Market: Competitive Landscape
Key players in the market are focused on adopting collaboration strategies to expand their product portfolio. For instance, in November 2017, Takeda Pharmaceutical and Portal Instruments entered into collaboration agreement to develop the needle-free drug delivery device with the Takeda Pharmaceuticals biologic medicines for hepatitis and Crohn’s disease.
Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/1681
On the basis of product type:
On the basis of the delivery site:
- Subcutaneous Injectors
- Intramuscular Injectors
- Intradermal Injectors
On the basis of the product lifecycle:
On the basis of technology:
- Jet-based needle-free injector
- Spring-based needle-free injector
- Laser-powered needle-free injector
On the basis of application:
- Vaccine and other biologic product delivery
- Insulin Delivery
On the basis of end-user:
- Hospitals & Clinics
- Home-based care
On the basis of geography:
- North America
- Latin America
- Asia Pacific
- Middle East
Have a Look at Related Research Insights:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027